3종의 배암차즈기에 대한 염증억제 활성 비교 및 활성성분 구명
Anti-Inflammatory Activity of Three Kinds of Salvia and Its Active Compounds
1
조회
0
다운로드
5
인용
0
참고문헌
키워드
초록
Background: Salvia has been widely cultivated for use in flavoring and folk medicines in many countries, including Korea and China. In this study, we investigated the anti-inflammatory activity and the underlying active compounds of Salvia extract and its fractions. Methods and Results: The anti-inflammatory activity was measured by assessing the inhibition of cysteinyl leukotriene production in rat basophilic leukemia (RBL)-2H3 mast cells. Salvia plebeia R. Br. was found to have the most potent inhibitory activity on leukotriene production than S. japonica and S. chanroenica had. Fifty percent ethanol extracts of S. plebeia R. Br. were successively partitioned with n-hexane, methylene chloride, ethyl acetate, 1-butanol and water. The ethyl acetate (EtOAc) fraction showed stronger anti-inflammatory activity than other solvent fractions did. The EtOAc fraction was subjected to silica gel column chromatography elution with a chloroform and methanol gradient system (100 : 1 → 1 : 1) yielding 10 fractions. Three kinds of fractions (chloroform:methanol = 20 : 1, 10 : 1 and 5 : 1) showed high inhibitory activity on leukotriene production. We confirmed the major compounds with anti-inflammatory activity from S. plebeia R. Br. Conclusions: In this study, the major components of S. plebeia that showed leukotriene production inhibitory activity were isolated using solvent extraction and silica gel column chromatography. Rosmarinic acid, hispidulin and luteolin were identified as the major compounds with anti-inflammatory effect.
Abstract
Background: Salvia has been widely cultivated for use in flavoring and folk medicines in many countries, including Korea and China. In this study, we investigated the anti-inflammatory activity and the underlying active compounds of Salvia extract and its fractions. Methods and Results: The anti-inflammatory activity was measured by assessing the inhibition of cysteinyl leukotriene production in rat basophilic leukemia (RBL)-2H3 mast cells. Salvia plebeia R. Br. was found to have the most potent inhibitory activity on leukotriene production than S. japonica and S. chanroenica had. Fifty percent ethanol extracts of S. plebeia R. Br. were successively partitioned with n-hexane, methylene chloride, ethyl acetate, 1-butanol and water. The ethyl acetate (EtOAc) fraction showed stronger anti-inflammatory activity than other solvent fractions did. The EtOAc fraction was subjected to silica gel column chromatography elution with a chloroform and methanol gradient system (100 : 1 → 1 : 1) yielding 10 fractions. Three kinds of fractions (chloroform:methanol = 20 : 1, 10 : 1 and 5 : 1) showed high inhibitory activity on leukotriene production. We confirmed the major compounds with anti-inflammatory activity from S. plebeia R. Br. Conclusions: In this study, the major components of S. plebeia that showed leukotriene production inhibitory activity were isolated using solvent extraction and silica gel column chromatography. Rosmarinic acid, hispidulin and luteolin were identified as the major compounds with anti-inflammatory effect.
참고문헌 (17)
- Barnes PJ, "Inflammatory mediators of asthma : An update", Pharmacological Reviews, 50, pp.515~596 (1998)
- Beasley R, "Risk factors for asthma: Is prevention possible?", The Lancet, 386, pp.1075~1085 (2015)
- Choi JK, "Salvia plebeia extract inhibits the inflammatory response in human rheumatoid synovial fibroblasts and a murine model of arthritis", Phytomedicine, 22, pp.415~422 (2015)
- 최수임, "추출조건에 따른 배암차즈기 추출물의 지방세포 분화 및 지방축적 억제 효과", 한국약용작물학회지, 23(3), pp.245~252 (2015), 한국약용작물학회[DOI]
- Drazen JM, "Treatment of asthma with drugs modifying the leukotriene pathway", New England Journal of Medicine, 340, pp.197~206 (1999)
- Elias JA, "New insights into the pathogenesis of asthma", The Journal of Clinical Investigation, 111, pp.291~297 (2003)
- Goulet JL, "Genetic factors determine the contribution of leukotrienes to acute inflammatory responses", The Journal of Immunology, 164, pp.4899~4907 (2000)
- Jung HJ, "Antiinflammatory, anti-angiogenic and anti-nociceptive activities of an ethanol extract of Salvia plebeia R. Brown", Journal of Ethnopharmacology, 126, pp.355~360 (2009)
- Liang Z, "Rosmarinic acid attenuates airway inflammation and hyperresponsiveness in a murine model of asthma", Molecules, 21, pp.769~774 (2016)
- 임진아, "배암차즈기 메탄올 추출물의 항산화 활성 및 아질산염 소거능", 한국약용작물학회지, 15(3), pp.183~188 (2007), 한국약용작물학회
- Maggi E., "The TH1", TH2 paradigm in allergy, 1998, pp.3, 233~244
- Minoguchi K, "Rehabilitation of the patient with respiratory disease", pp.97~104 (1999), McGraw-Hill
- Pawankar R., "Mast cells as orchestrators of the allergic reaction: The IgE-IgE receptor mast cell network", Current Opinion in Allergy and Clinical Immunology, 1, pp.3~6 (2001)
- Ren DB, "Separation of nine compounds from Salvia plebeia R. Br. using two-step high-speed counter-current chromatography with different elution modes", Journal of Separation Science, 37, pp.2118~2125 (2014)
- Shimizu H, "Critical role of interleukin-5 in the development of a mite antigen-induced chronic bronchial asthma model", Inflammation Research, 62, pp.911~917 (2013)
- Wills-Karp M, "Interleukin-13 : Central mediator of allergic asthma", Science, 282, pp.2258~2261 (1998)
- Wynn TA, "Type 2 cytokines : Mechanisms and therapeutic strategies", Nature Reviews Immunology, 15, pp.271~282 (2015)